Hansoh heralds China’s move from ‘follower’ to ‘frontrunner’
Hansoh heralds China’s move from ‘follower’ to ‘frontrunner’
Hansoh Pharmaceutical Group is a China-based biopharmaceutical company with marketed products and development programs across oncology, central nervous system disorders, anti-infectives, metabolic disease, and autoimmune disease.
Hansoh heralds China’s move from ‘follower’ to ‘frontrunner’
BioSpace reports: GSK and Hansoh’s ADC clinches late-stage win, teeing up regulatory submission in China.
Founder and Chairman